ES401
/ Elpiscience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
ES401, a novel biparatopic CDH17-targeting antibody-drug conjugate for cancer therapy
(SITC 2026)
- No abstract available
ADC • Oncology • CDH17
1 to 1
Of
1
Go to page
1